Spacing Pfizer COVID jabs boosts antibody levels: UK study
A longer gap between doses of Pfizer’s COVID-19 vaccine leads to higher overall antibody levels than a shorter gap, a UK study has found, but antibody levels are not sustained for long after the first dose. The University of Oxford-led study might help inform vaccination strategies against the Delta variant, which reduces the effectiveness of…

